Direkt zum Inhalt
Merck
  • Discovery of simplified benzazole fragments derived from the marine benzosceptrin B as necroptosis inhibitors involving the receptor interacting protein Kinase-1.

Discovery of simplified benzazole fragments derived from the marine benzosceptrin B as necroptosis inhibitors involving the receptor interacting protein Kinase-1.

European journal of medicinal chemistry (2020-07-14)
Mohamed Benchekroun, Ludmila Ermolenko, Minh Quan Tran, Agathe Vagneux, Hristo Nedev, Claire Delehouzé, Mohamed Souab, Blandine Baratte, Béatrice Josselin, Bogdan I Iorga, Sandrine Ruchaud, Stéphane Bach, Ali Al-Mourabit
ZUSAMMENFASSUNG

With the aim to develop new chemical tools based on simplified natural metabolites to help deciphering the molecular mechanism of necroptosis, simplified benzazole fragments including 2-aminobenzimidazole and the 2-aminobenzothiazole analogs were prepared during the synthesis of the marine benzosceptrin B. Conpounds inhibiting the RIPK1 protein kinase were discovered. A library of 54 synthetic analogs were prepared and evaluated through a phenotypic screen using the inhibition of the necrotic cell death induced by TNF-α in human Jurkat T cells deficient for the FADD protein. This article reports the design, synthesis and biological evaluation of a series of 2-aminobenzazoles on the necroptotic cell death through the inhibition of RIPK1 protein kinase. The 2-aminobenzimidazole and 2-aminobenzothiazole platforms presented herein can serve as novel chemical tools to study the molecular regulation of necroptosis and further develop lead drug candidates for chronic pathologies involving necroptosis.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Staurosporin aus Streptomyces sp., for molecular biology, ≥95% (HPLC)
Sigma-Aldrich
Histon aus Kalbsthymus, Type III-S
Sigma-Aldrich
Indirubin-3′-oxime, ≥98% (HPLC), solid
Sigma-Aldrich
CHR-6494 trifluoroacetate salt, ≥98% (HPLC)